Mayinglong Pharmaceutical Group Company Limited manufactures and markets traditional Chinese medicines and western medicines for the treatment of hemorrhoids and cough.

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025

Report for Q3 2025

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Mayinglong Pharmaceutical A (600993 CH)

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025

Report for Q3 2025

Announcement on Canceling the Board of Supervisors, Amending the Articles of Association, and Revising and Formulating Some Governance Systems

Notice on Convening the 1st Extraordinary General Meeting in 2025

Announcement on Resolutions of the 22nd Meeting of the 11th Board of Directors

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)